Step 2: Provider reviews your file and approves your prescription
The findings were striking: up to a 4 kg difference in average weight change between agents, along with significant variability in cardiometabolic markers
The most common typically strongest in the first 48 weeks as the body adapts include: Nausea (most common, usually dose-dependent) Diarrhoea or constipation Fatigue , especially during dose escalations Mild headache Reflux and acid reflux Loss of appetite (this is the therapeutic effect, not a side effect, but it can be uncomfortable) Less common but more serious effects warranting immediate physician review include pancreatitis, gallbladder disease, and kidney issues, particularly in patients with pre-existing conditions
Tirzepatide shifts the balance of insulin and glucagon toward greater insulin action and reduced glucagon release, leading to improved glucose control and decreased hunger
Wegovy is available currently in the following strengths: 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg
Evening Injections: What the Evidence Shows Neither morning nor evening GLP-1 injections have been proven superior in clinical trials, which means your choice can align with personal preference and daily habits
:max_bytes(150000):strip_icc()/WhatstheDifferenceBetweenOzempicWegovyandMounjaro-illo-a8f5a23fe4914586b4488472fe15f112.png)
